Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||
| Net Income | -23,056 | N/A | N/A |
| Depreciation Amortization | 237 | N/A | N/A |
| Accounts payable and accrued liabilities | 571 | N/A | N/A |
| Other Working Capital | 747 | N/A | N/A |
| Other Operating Activity | 459 | 0 | 0 |
| Operating Cash Flow | $-21,042 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||
| Change In Deposits | -24,712 | N/A | N/A |
| PPE Investments | -216 | N/A | N/A |
| Investing Cash Flow | $-24,928 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Debt Issued | 17,666 | N/A | N/A |
| Common Stock Issued | 157 | N/A | N/A |
| Other Financing Activity | 32,093 | 0 | 0 |
| Financing Cash Flow | $49,916 | $N/A | $N/A |
| Beginning Cash Position | 4,204 | N/A | N/A |
| End Cash Position | 8,150 | N/A | N/A |
| Net Cash Flow | $3,946 | $N/A | $N/A |
| Free Cash Flow | |||
| Operating Cash Flow | -21,042 | N/A | N/A |
| Capital Expenditure | -231 | N/A | N/A |
| Free Cash Flow | -21,273 | 0 | 0 |